Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Market Cap	33.80B +4.8%
Revenue (ttm)	7.10B +13.1%
Net Income	1.52B +14.5%
EPS	13.59 +14.5%
Shares Out	111.93M
PE Ratio	22.22
Forward PE	20.10
Dividend	5.20 (1.74%)
Ex-Dividend Date	n/a

Volume	182,703
Average Volume	152,573
Open	302.00
Previous Close	299.30
Day's Range	300.00 - 307.40
52-Week Range	251.95 - 366.25
Beta	0.45
RSI	62.01
Earnings Date	May 15, 2026

About NSE:ADVENZYMES

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1957
• Employees: 338
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ADVENZYMES

Financial Performance

In fiscal year 2025, NSE:ADVENZYMES's revenue was 6.37 billion, an increase of 2.09% compared to the previous year's 6.24 billion. Earnings were 1.31 billion, a decrease of -1.64%.